New York Life Investment Management LLC Catalyst Pharmaceuticals, Inc. Transaction History

New York Life Investment Management LLC

  • $9.63 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
BUY
$13.18 - $17.11 $298,395 - $387,370
22,640 New
22,640 $360,000
Q4 2022

Feb 10, 2023
BUY
$12.25 - $19.5 $89,915 - $143,130
7,340 Added 12.02%
68,427 $1.27 Million
Q3 2022

Nov 10, 2022
BUY
$7.06 - $15.52 $34,128 - $75,023
4,834 Added 8.59%
61,087 $784,000
Q2 2022

Aug 12, 2022
BUY
$6.23 - $8.57 $350,456 - $482,088
56,253 New
56,253 $394,000

Others Institutions Holding CPRX

# of Institutions
326
Shares Held
94.6M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.12B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email